taxonomy (4)
protein (23)
source (7)
structure (3)
composition (1)
disease (3)
reference (11)
site (36)
peptide (33)
- Homo sapiens (Human)
- Mus musculus (House mouse)
- Columba livia (Domestic pigeon)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Biglycan / Homo sapiens P21810
- Clusterin / Homo sapiens P10909
- Complement c4-a / Homo sapiens P0C0L4
- Complement C4-B / Homo sapiens P0C0L5
- Complement factor b / Homo sapiens P00751
- Fibronectin / Homo sapiens P02751
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens P01215
- Golgi apparatus protein 1 / Homo sapiens Q92896
- Lactotransferrin / Homo sapiens P02788
- Leucine-rich repeat transmembrane protein FLRT3 / Homo sapiens Q9NZU0
- Lutropin beta chain / Homo sapiens P01229
- Prosaposin / Homo sapiens P07602
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen (psa-1) / Homo sapiens P07288
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens Q9BYF1
- Thrombospondin-1 / Homo sapiens P07996
- Uromodulin / Homo sapiens P07911
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Myelin-oligodendrocyte glycoprotein / Mus musculus Q61885
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Immunoglobulin gamma / Columba livia
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Pituitary Gland (UBERON_0000007)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
Source
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)HexNAc(b1-?)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 1180
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
Reported structure
- Hex:4 HexNAc:5 NeuAc:2 (avg mass : 2265.0757 )
Composition
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- N-glycan structures of pigeon IgG: a major serum glycoprotein containing Galalpha1-4 Gal termini.. (2003 - Suzuki N, Khoo KH, Chen CM, Chen HC, Lee YC) / Status : Reviewed
- NMR investigations of the N-linked oligosaccharides at individual glycosylation sites of human lutropin. (1991 - Weisshaar G, Hiyama J, Renwick A, Nimtz M) / Status : Reviewed
Reference
- Biglycan / Homo sapiens
- Clusterin / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement C4-B / Homo sapiens
- Complement factor b / Homo sapiens
- Fibronectin / Homo sapiens
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Leucine-rich repeat transmembrane protein FLRT3 / Homo sapiens
- Lutropin beta chain / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Uromodulin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
-
Immunoglobulin gamma / Columba livia
- Undefined site
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- FVFLVLLPLVSSQCVNLTTRTQ (22aa)
- HENNTKDNSIQHEFSLTR (18aa)
- NTNITEENVQNMNNAGDK (18aa)
- ISPGKNATGMEVGWYR (16aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- FHAIHVSGTNGTKRF (15aa)
- KEDALNETR (9aa)
- TQSLLIVNNATNVVIK (16aa)
- FGCEIENNR (9aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- LNLTTDPK (8aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VFFNLVNLTELSLVR (15aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- IYLVLDGSDSIGASNFTGAK (20aa)
- IIQVVYIHSNNITK (14aa)
- FPNITNLCPFGE (12aa)
- RFPNIT (6aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- IANITQGEDQYYIR (14aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- DQCIVDDITYNVNDTFHK (18aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGA (34aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- TAPKNVSDIIPR (12aa)
- VVNSTTGPGEHIR (13aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYD (48aa)
- YFKNHTSPDVDLGDISGINA (20aa)
- NTTCQDLQIEVTVK (14aa)
- NTTCQDLQIEVTVK (14aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 2265.0757)
-
Immunoglobulin gamma / Columba livia
- Undefined site
-
- N-Linked / Complex (avg mass : 2265.0757)
- Prostate-specific antigen (psa-1) / Homo sapiens
-
- N-Linked / Complex (avg mass : 2265.0757)
- Pituitary Gland (UBERON_0000007)
- Glycoprotein hormones alpha chain - choriogonadotropin / Homo sapiens
- Lutropin beta chain / Homo sapiens
-
- Hex:4 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2265.0757)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[NeuAc(a2-6)GalNAc(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Biglycan / Homo sapiens
- Clusterin / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement C4-B / Homo sapiens
- Complement factor b / Homo sapiens
- Fibronectin / Homo sapiens
- Golgi apparatus protein 1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Leucine-rich repeat transmembrane protein FLRT3 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 - DRAFT DATA / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Uromodulin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- FVFLVLLPLVSSQCVNLTTRTQ (22aa)
- HENNTKDNSIQHEFSLTR (18aa)
- NTNITEENVQNMNNAGDK (18aa)
- ISPGKNATGMEVGWYR (16aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- FHAIHVSGTNGTKRF (15aa)
- KEDALNETR (9aa)
- TQSLLIVNNATNVVIK (16aa)
- FGCEIENNR (9aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- LNLTTDPK (8aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VFFNLVNLTELSLVR (15aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- IYLVLDGSDSIGASNFTGAK (20aa)
- IIQVVYIHSNNITK (14aa)
- FPNITNLCPFGE (12aa)
- RFPNIT (6aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- IANITQGEDQYYIR (14aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- FALLMTNCYATPSSNATDPLK (21aa)
- DQCIVDDITYNVNDTFHK (18aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGA (34aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- TAPKNVSDIIPR (12aa)
- VVNSTTGPGEHIR (13aa)
- EGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYD (48aa)
- YFKNHTSPDVDLGDISGINA (20aa)
- NTTCQDLQIEVTVK (14aa)
- NTTCQDLQIEVTVK (14aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
